Charnwood Molecular, a leading UK-based pre-clinical discovery CRO serving the global pharmaceutical and biotechnology market, has added a range of new solid-state capabilities to its portfolio through a new collaborative partnership with Barcelona-based Solitek. The sector-leading expertise and technology development within Solitek combines an excellent understanding...
NanoSyrinx has raised a further £6.2m of seed financing, co-led by incoming Octopus Ventures and existing investor M Ventures (Amsterdam, The Netherlands), the corporate venture capital arm of Merck KGaA. Previous investors BioCity and the UK Innovation & Science Seed Fund (UKI2S) joined the funding...
WAPG's MediCity Nottingham based NuVision Biotherapies has come up with a product, which helps to heal eye injuries efficiently and wants to revolutionise the treatment of other wounds. The company recently picked up £1.8 million funding. This is the fourth fundraising round secured by NuVision...
WOMEN can now buy a contraceptive pill over the counter without a prescription following a consultation with a pharmacist after the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) today granted a licence to Maxwellia’s Lovima®. This reclassification of the daily progestogen-only pill is one of the...
Research published today has demonstrated the viability of 3D-printed tissue scaffolds that harmlessly degrade while promoting tissue regeneration following implantation. The scaffolds showed highly promising tissue-healing performance, including the ability to support cell migration, the ‘ingrowth’ of tissues, and revascularisation (blood vessel growth). Professor Andrew Dove, from...
A company, which has played a vital role in the fight against COVID-19, has received a Queen’s Award for Enterprise in International Trade. Absolute Antibody, based at the Wilton Centre, a WAPG site near Redcar, was told 14 months ago that it was being given the...
6 life science companies from the West Midlands and 6 from the East Midlands were delighted to be selected as winners at yesterday’s Medilink Midlands Business Awards, which saw over 130 businesspeople from life science companies across the region and beyond come together online to...
BioCity Nottingham based Sygnature Discovery, the leading provider of integrated drug discovery services, has received a significant investment from Five Arrows Principal Investments, the European corporate private equity arm of Rothschild & Co. Financial details have not been disclosed. Sygnature is a world-class provider of outsourced...
The best and brightest Life Sciences companies from across the Midlands have been shortlisted for the Medilink Midlands Business Awards 2021. This free awards ceremony will take place online, on Wednesday 30 June, from 3:00pm to 6:00pm The business awards celebrate the achievements, breakthroughs and innovations...
ARU is chosen to deliver world’s largest healthcare entrepreneurship programme Anglia Ruskin University (ARU) has been chosen as the official partner of NHS England and NHS Improvement to nurture healthcare innovators from across the country and help them gain the commercial skills, knowledge and experience to...